Literature DB >> 14700092

Distribution of axial, corneal, and combined ametropia in a refractive surgery unit.

Gy Barcsay1, Z Zs Nagy, J Németh.   

Abstract

PURPOSE: To group eyes in our refractive surgery unit on the basis of the origin of their ametropia and to assess the percentage of eyes in the different groups.
METHODS: Refractive parameters and the axial eye length (AL) of 131 eyes of 131 persons with different refraction were measured. The eyes were initially classified into five groups on the basis of the grade of their ametropia: hypermetropic (> +0.5 D, n = 35), emmetropic (between +/- 0.5 D, n = 24), low myopic (between -0.75 and -4.0 D, n = 24), medium myopic (between -4.25 and -8.0 D, n = 24), and high myopic (over -8.0 D, n = 24). Then a classification scheme was made to group the origin of the ametropia on the basis of AL and corneal refractive power.
RESULTS: In the hypermetropic group pure corneal origin was found in 8.6%, pure axial origin in 62.8%, and combined origin in 28.6% of the eyes. In the low myopic group these values were 20.9%, 29.2%, and 45.8%, respectively. In the medium and high myopic groups no pure corneal myopia was found, while axial myopia was found in 16.7% and combined myopia in 83.3% of the eyes.
CONCLUSIONS: With the help of the classification scheme, an objective decision could be made as to whether the ametropia of a particular eye had axial, corneal, or mixed origin. The most interesting result was that in 83% of medium and high myopic eyes not only AL but also corneal refractive power contributed to the refractive error instead of the eyes being purely axially myopic.

Entities:  

Mesh:

Year:  2003        PMID: 14700092     DOI: 10.1177/1120672103013009-1001

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  1 in total

1.  Prevalence of refractive errors in Hungary reveals three-fold increase in myopia.

Authors:  János Németh; Tennó Daiki; Gergely Dankovics; István Barna; Hans Limburg; Zoltán Zsolt Nagy
Journal:  Int J Ophthalmol       Date:  2022-07-18       Impact factor: 1.645

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.